About Applied DNA Sciences

Applied DNA Sciences (NASDAQ: APDN) is a biotechnology company developing and commercializing technologies to produce and detect DNA and RNA.

Using PCR to enable the production and detection of DNA and RNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics (including biologics and drugs) and, through our recent acquisition of Spindle Biotech, Inc. (“Spindle”), the development and sale of a proprietary RNA polymerase (“RNAP”) for use in the production of messenger RNA (“mRNA”) therapeutics (“Therapeutic DNA Production Services”); (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services (“MDx Testing Services”); and (iii) the manufacture and detection of DNA for industrial supply chain security services (“DNA Tagging and Security Products and Services”).

Want to learn more? Contact us today. 
info@adnas.com | 631.240.8800